Ethiopropamine
|  | |
| Clinical data | |
|---|---|
| Other names | EPA; N-Ethylthiopropamine | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C9H15NS | 
| Molar mass | 169.29 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Ethiopropamine (EPA), also known as N-ethylthiopropamine, is a stimulant drug which is the ethyl homologue of methiopropamine, or the thiophene analogue of ethamphetamine. It has been sold as a designer drug, first identified in Slovenia in 2021.[1]
See also
References
- ^ "Analytical Report Ethiopropamine" (PDF). Nacionalni Forenzicni Laboratorij. 23 July 2021.
    This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.